RIIPL is pleased to announce a lecture by Canadian expert and commentator Mark Warner on April 9 at noon at the law school. Mark Warner will speak about a range of current competition, trade, investment and IP issues involving the pharmaceutical industry in Canada and the implications for U.S. investors and policymakers. He will discuss the Competition Bureau’s approach to agreements between brands and generic manufacturers, Lilly’s NAFTA challenge to Canada’s patent regime, IP issues in trade negotiations, and an expected April landmark Supreme Court decision on compensation to generic manufacturers following failed patent litigation by brands. Mr. Warner is a Canadian/U.S. attorney who has practiced with leading law firms in Washington, New York, Brussels, and Toronto providing advice on a range of transactional and regulatory issues related to antitrust, trade, and investment law. He is a former counsel to the OECD on trade and competition issues and advised a leading pharmaceutical company on its global distribution of antiretroviral drugs. Mr. Warner has held leadership positions in the American Bar Association, and is a Fellow of the American Bar Foundation, a former Canadian politician, and a media commentator.